Dr. Karol Sikora Accepts Appointment to MEI Healthcare Group’s Board of Directors

By Mei Healthcare Group, PRNE
Monday, July 18, 2011

CORAL SPRINGS, Florida, July 19, 2011 -


MEI Healthcare Group, a leading provider of healthcare
strategies and equipment solutions to medical facilities around the
world, announced today that Dr. Karol Sikora has accepted an
appointment to the company’s board of directors. Sikora is the
medical director of CancerPartnersUK, the largest independent
cancer network in the UK, and is dean of medicine at the University
of Buckingham, Britain’s first independent medical school. Sikora
was previously Chief of the World Health Organization’s cancer
programme and served as professor and chairman of the Department of
Cancer Medicine at Imperial College School of Medicine. He is
currently an honorary consultant oncologist at Hammersmith Hospital
in London, where he served as clinical director for cancer services
for 12 years, and is a fellow of Corpus Christi College in
Cambridge.

“We are delighted to have Professor Sikora as a member of our
board. His vision and experience on the international stage in both
the public and private sectors will be a major asset to the MEI
Healthcare Group,” said MEI board chair Dr. Arthur Porter.

While serving at Hammersmith Hospital, Sikora chaired that
facility’s fundraising campaign, an appeal that raised 8m pounds
Sterling
to construct the Cancer Centre at Hammersmith.
 Later, he became vice president for Pharmacia Corporation and
managed the company’s global clinical research for oncology. He is
currently an adviser to the World Health Organization, the
International Atomic Energy Agency (IAEA) and is a member of the UK
Health Department’s Expert Advisory Group on Cancer.

Sikora has published more than 300 papers and written or edited
20 books including Treatment of Cancer - the standard
British postgraduate textbook now in its fifth edition and, most
recently, The Economics of Cancer Care.  He is on the
editorial board of several journals and is the founding editor of
Gene Therapy and Cancer Strategy.

MEI provides business development, capital equipment funding
strategies and growth consulting services to physicians, hospitals
and healthcare systems worldwide.

About MEI Healthcare Group

Headquartered in Coral Springs, Fla., MEI is a comprehensive
healthcare strategy firm that works with physician groups and
medical centers to provide turnkey healthcare solutions. MEI and
its subsidiaries, MEI Development Corporation, MEI Healthcare
Capital, MEI Informatics, MEI Healthcare International and MEI
Healthcare Foundation, offer its clients more than 40 years of
healthcare business experience and the value-added benefits of its
strategic alliances. For more information, visit href="www.mei.com/">www.mei.com

CONTACT:
Tyler Lecceadone
SeyferthPR
+1-800-435-9539
Lecceadone@seyferthpr.com

.

Pharmaceuticals News

July 19 News

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :